Type 1.5 diabetes (LADA)
Pro Research Analysisby 
Searched over 200M research papers
Overview of Type 1.5 Diabetes (LADA): Definition and Prevalence
Latent autoimmune diabetes in adults (LADA), also called type 1.5 diabetes, is a form of diabetes that shares features of both type 1 and type 2 diabetes. It is an autoimmune condition that typically develops in adults, often between the ages of 30 and 45, and accounts for about 5-10% of all diabetes cases, though prevalence can vary by ethnicity and population studied 1234+1 MORE.
Pathophysiology and Autoimmune Markers in LADA
LADA is characterized by the presence of autoantibodies against pancreatic beta cells, most commonly glutamic acid decarboxylase (GAD), islet antigen-2 (IA-2), and sometimes insulin autoantibodies. These autoantibodies lead to a slow, progressive destruction of beta cells, resulting in a gradual decline in insulin production. Unlike classic type 1 diabetes, the autoimmune process in LADA is less aggressive, which explains the slower progression to insulin dependence 235.
Clinical Features and Diagnostic Challenges
Patients with LADA often present with symptoms similar to type 2 diabetes, such as excessive thirst, frequent urination, and fatigue, but they usually have a normal body mass index (BMI) and may have other autoimmune diseases. The overlap in clinical features with type 2 diabetes can make diagnosis challenging, especially since LADA patients do not require insulin at the onset and may initially respond to oral diabetes medications 1346.
Screening for islet cell autoantibodies, especially GAD antibodies, is essential for distinguishing LADA from type 2 diabetes. The presence of these antibodies, even at low titers, is a key diagnostic marker, but the risk of rapid beta-cell failure increases with the number and level of autoantibodies detected 234.
Disease Progression and Management Strategies
LADA progresses more slowly than classic type 1 diabetes, but patients eventually become highly insulin dependent due to ongoing beta-cell destruction. Early and accurate diagnosis is important because management differs from type 2 diabetes. Early initiation of insulin therapy is recommended to preserve remaining beta-cell function and delay complete insulin dependence 136.
Patients with LADA often have lower BMI, blood pressure, and triglyceride levels compared to those with classic type 2 diabetes, but they share some degree of insulin resistance. Management should focus on early insulin therapy and regular monitoring of beta-cell function, with the goal of delaying disease progression 236.
Importance of Awareness and Early Detection
LADA is frequently underdiagnosed or misdiagnosed as type 2 diabetes, leading to suboptimal treatment. Increased awareness among healthcare providers and improved screening methods are crucial for early identification and appropriate management of LADA. Recognizing the unique features of LADA can help tailor treatment strategies and improve patient outcomes 1345+1 MORE.
Conclusion
Type 1.5 diabetes (LADA) is a distinct form of autoimmune diabetes in adults that combines features of both type 1 and type 2 diabetes. Accurate diagnosis relies on detecting islet cell autoantibodies, and early insulin therapy is key to preserving pancreatic function. Greater awareness and early detection are essential for optimal management and improved long-term outcomes in patients with LADA 1234+2 MORE.
Sources and full results
Most relevant research papers on this topic
Progress in the characterization of slowly progressive autoimmune diabetes in adult patients (LADA or type 1.5 diabetes).
LADA or type 1.5 diabetes is a slowly progressive autoimmune diabetes in adults, with low antibody titers against islet-cell antigens potentially causing a less aggressive form of autoimmune diabetes.
DOI